"Human papillomavirus 16" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.
| Descriptor ID |
D052162
|
| MeSH Number(s) |
B04.280.210.655.050.616 B04.613.204.655.050.616
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human papillomavirus 16".
Below are MeSH descriptors whose meaning is more specific than "Human papillomavirus 16".
This graph shows the total number of publications written about "Human papillomavirus 16" by people in this website by year, and whether "Human papillomavirus 16" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 22 | 8 | 30 |
| 2018 | 8 | 11 | 19 |
| 2019 | 6 | 5 | 11 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Human papillomavirus 16" by people in Profiles.
-
Selenium atom on phosphate enhances specificity and sensitivity of DNA polymerization and detection. J Mater Chem B. 2021 07 21; 9(28):5636-5644.
-
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia. Clin Infect Dis. 2020 06 10; 70(12):2582-2590.
-
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18. Am J Epidemiol. 2020 04 02; 189(4):265-276.
-
Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development. Gynecol Oncol. 2019 10; 155(1):151-160.
-
Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions. Vaccine. 2019 08 23; 37(36):5460-5465.
-
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial. Cancer Med. 2019 10; 8(14):6195-6211.
-
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women. Sci China Life Sci. 2020 Apr; 63(4):582-591.
-
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. Lancet Infect Dis. 2019 08; 19(8):880-891.
-
HPV detection and genotyping of head and neck cancer biopsies by molecular testing with regard to the new oropharyngeal squamous cell carcinoma classification based on HPV status. Pathology. 2019 Jun; 51(4):421-425.
-
Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province. Women Health. 2019 Nov-Dec; 59(10):1105-1117.